Attitude towards the disease and quality of life of patients with multiple sclerosis as a target of personalized psychotherapy for PTSD

Attitude towards the disease and quality of life of patients with multiple sclerosis as a target of personalized psychotherapy for PTSD

Attitude towards the disease and quality of life of patients with multiple sclerosis as a target of personalized psychotherapy for PTSDA chronic, progressive, potentially disabling disease with a poor prognosis can trigger the development of post-traumatic stress disorder (PTSD). The article present...

Full description

Bibliographic Details
Main Authors:	M. T. Andreeva, T. A. Karavaeva, I. V. Kalinin
Format:	Article
Language:	Russian
Published:	Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2021-12-01
Series:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:	post-traumatic stress disorder multiple sclerosis quality of life internal picture of the disease attitude to the disease anxiety about progression targets of psychotherapy
Online Access:	https://www.bekhterevreview.com/jour/article/view/619

Similar Items

Psychic trauma and mental characteristics of patients with multiple sclerosis as predictors of post-traumatic stress disorder and targets for psychotherapy
by: M. T. Andreeva, et al.
Published: (2022-10-01)

Identification and characteristics of post-traumatic stress disorder in patients with multiple sclerosis
by: M. T. Andreeva, et al.
Published: (2020-10-01)

Developing a cultural psychotherapy package based on Quranic verses and mystical themes of Mantiq al-Tair among women with multiple sclerosis (MS)
by: Marzieh Hajibabaei, et al.
Published: (2020-12-01)

MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
by: Kainat Riaz, et al.
Published: (2023-11-01)

Addressing Attrition from Psychotherapy for PTSD in the U.S. Department of Veterans Affairs
by: Alexander J. Lee, et al.
Published: (2023-11-01)

Clinical characteristics of multiple sclerosis in the Tomsk region
by: V M Alifirova, et al.
Published: (2012-06-01)

Consensus on early detection of disease progression in patients with multiple sclerosis
by: José E. Meca-Lallana, et al.
Published: (2022-07-01)

Progression of Relapsing-Remitting Multiple Sclerosis despite the new era of treatments
by: Gutemberg Augusto Cruz dos Santos, et al.
Published: (2022-12-01)

Effect of disease duration on personality type in multiple sclerosis patients and healthy individual
by: Sahar Vesal, et al.
Published: (2016-01-01)

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021
by: Crystal Watson, et al.
Published: (2023-09-01)

MicroRNAs as biomarkers of multiple sclerosis progression
by: N. M. Baulina, et al.
Published: (2023-08-01)

Late onset multiple sclerosis: concerns in aging patients
by: Claudia Beatriz de Campos Lotti, et al.

Mitochondrial Dysfunction in Multiple Sclerosis: A Systematic Review
by: Alia Saberi, et al.
Published: (2019-02-01)

Patterns of multiple sclerosis presentation to the emergency department
by: Seraj Makkawi, et al.
Published: (2024-04-01)

Association of smoking with disease progression in persons with multiple sclerosis undergoing autologous hematopoietic cell transplantation: a single-center experience
by: Danitza Fernandez-Lara, et al.
Published: (2024-01-01)

A new psychotherapy that may treat PTSD in one session
by: Edmund Howe
Published: (2024-11-01)

Attitudes of psychotherapists towards pharmacotherapy in the course of psychotherapy
by: Sławomir Murawiec, et al.
Published: (2017-06-01)

Anxiety in Patients with Multiple Sclerosis: Association with Disability, Depression, Disease Type and Sex
by: Fariba Askari, et al.
Published: (2014-12-01)

A future of AI-driven personalized care for people with multiple sclerosis
by: Jelle Praet, et al.
Published: (2024-08-01)

Impact of dissociation on the effectiveness of psychotherapy for post-traumatic stress disorder: meta-analysis
by: C. M. Hoeboer, et al.
Published: (2020-05-01)

B. D. Karvasarsky and psychotherapy establishment as a distinct discipline, homo faber, to the 90-th anniversary since birth
by: A. V. Vasileva, et al.
Published: (2021-12-01)

Machine Learning Use for Prognostic Purposes in Multiple Sclerosis
by: Ruggiero Seccia, et al.
Published: (2021-02-01)

Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background
by: Eva J. Brandl, et al.
Published: (2020-04-01)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
by: Katelijn M. Blok, et al.
Published: (2023-11-01)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
by: Katharina Breitkopf, et al.
Published: (2020-08-01)

Associated Psychological Disorders and Impairment of Emotional Regulation among Patients with Multiple Sclerosis
by: M. T. Andreeva, et al.
Published: (2020-01-01)

Iron Rim Lesions as a Specific and Prognostic Biomarker of Multiple Sclerosis: 3T-Based Susceptibility-Weighted Imaging
by: Sooyoung Kim, et al.
Published: (2023-05-01)

Dynamics of clinical and psychological indicators of patients with anxiety neurotic disorders in the treatment of short-term individual analytical-catarrhal psychotherapy
by: E. G. Ilchenko, et al.
Published: (2019-02-01)

Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases
by: Priyadarshi Prajjwal, et al.
Published: (2023-07-01)

The First Hospital-Based Registry of Patients with Multiple Sclerosis in Croatia
by: Vanja Bašić Kes, et al.
Published: (2017-01-01)

Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
by: Iciar Martínez-López, et al.
Published: (2020-04-01)

Optimization of therapy in secondary progressive multiple sclerosis
by: A. N. Boyko, et al.
Published: (2024-08-01)

Validation of a Set of Clinical Criteria for the Diagnosis of Secondary Progressive Multiple Sclerosis
by: Alin Ciubotaru, et al.
Published: (2024-11-01)

Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients with Multiple Sclerosis
by: Marjan Jamalian, et al.
Published: (2018-01-01)

Personality-guided therapy for posttraumatic stress disorder /
by: Everly, George S., 1950-, et al.
Published: (2004)

Demographic and disease‐related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
by: Kamila Zondra Revendova, et al.
Published: (2023-01-01)

NEUROFILAMENTS AS A POTENTIAL BIOMARKER IN PATIENTS WITH MULTIPLE SCLEROSIS: A REVIEW OF LITERATURE
by: Magdalina Yanakieva, et al.
Published: (2024-05-01)

It's not all in your head : anxiety, depression, mood swings, and multiple sclerosis /
by: Farrell, Patricia, 1940-
Published: ([201)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

Multiple sclerosis and personality traits: associations with depression and anxiety
by: Saeed Vaheb, et al.
Published: (2024-03-01)